CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Clinical trial NCT06690775 · RECRUITING

Trial details

NCT number: NCT06690775
Sponsor: TORL Biotherapeutics, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Primary Peritoneal Fallopian Tube Cancer Endometrioid Ovarian Cancer

Start date: 2024-11-20
Primary completion: 2027-10-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.